References
Osler, W. On the visceral complications of erythema exudativum multiformae. Am J Med Sci, 1895, 110, 629.
Lipman, E., Sacks, B. A hitherto undescribed form of vascular and mural endocarditis. Trans Assoc Am Phys, 1923, 38, 46.
Rose, E., Pillsbury, D.M. Acute disseminated lupus erythematosus — a systemic disease. Ann Intern Med, 1939, 12, 951.
Hargraves, M.M., Richmond, H., Morton, R. Presentation of two bone marrow elements: the ‘tart’ cell and the ‘LE’ cell. Proceedings of the Mayo Clinic, 1948, 23, 25–28.
Harvey, A.M., Shulman, L.E., Tumulty, P.A. et al. Systemic lupus erythematosus. Review of the literature and clinical analysis of 138 cases. Baltimore, The Williams & Wilkins Company, 1955.
Fries, J.F., Holman, H.R. Recent evolution of systemic lupus erythematosus. In: Systemic lupus erythematosus. A clinical analysis, Vol. VI Major problems in internal medicine, W.B. Saunders Company, 1975, 2–7.
Fries, J.F., Weyl, S., Holman, H.R. Estimating prognosis in systemic lupus erythematosus. Am J Med, 1974, 57, 562.
Perry, H.M., Schroeder, H.A. Syndrome simulating collagen disease caused by hydralazine (apresoline). J Am Med Assoc, 1954, 154, 670–673.
Dustan, H.P., Taylor, R.D., Corcoran, AC, Page, I.H. Rheumatic and febrile syndrome during prolonged hydralazine therapy. J Am Med Assoc, 1954, 154, 23–39.
Ladd, A.T. Procainamide-included lupus erythematosus. N Engl J Med, 1962, 267, 1357–1358.
Tan, E.M., Portanova, J.P. The role of histones as auto-antigens in drug-related lupus erythematosus. Arthritis Rheum, 1981, 24, 1064–1069.
Rodnan, G.P., Benedek, T.G. An historical account of the study of progressive systemic aclerosis (diffuse scleroderma). Ann Inter Med, 1962, 57, 305–319.
Rodnan, G.P., Benedek, T.G. History of scleroderma. Ann Intern Med, 1978, 89, 725.
Curzio, C. Discussioni Anatomico-Pratiche di un raro, e stravagante morbo cutaneo in uno giovane Donna felicemente curato in questo grande Ostedale degl'Incruabili. Napoli: Giovanni de Simone, 1753.
Goetz, R.H. Pathology of progressive systemic sclerosis (generalised scleroderma) with special reference to changes in the viscera. Clinical Proceedings. J Cape Town Post-Grad Med Assoc, 1945, 4, 337–392.
Medsger, T.A. Jr., Masi, A.T. Epidemiology of systemic sclerosis (scleroderma). Ann Inter Med, 1971, 74, 714–721.
Kurland, L.T., Hauser, W.A., Ferguson, R.H., Holley, K.E. Epidemiologic features of diffuse connective tissue disorders in Rochester, Minnesota, 1951 through 1967, with special reference to systemic lupus erythematosus. Mayo Clin Proc, 1969, 44, 469–663.
Hadden, W.B. On “dry mouth”, or suppression of the salivary and buccal secretions. Trans Clin Soc London, 1888, 21, 176.
Houwer, A.W.M. Keratitis filamentosa and chronic arthritis. Tr Ophtal Soc UK, 1927, 47, 88.
Sjögren, H. Zur Kenntnis der Keratoconjunctivitis sicca (Keratitis filiformis bei hypofunktion der Tränendrüsen). Acta Ophtal. (Kbh), 1933, 11, 1.
Clark, G.M., Reichlin Tomasi M.T.B., Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol, 1969, 102, 117.
Matticli, M., Reichlin, M. Heterogeneity of RNA protein antigens reactive with sera of patients with systemic lupus erythematosus. Description of a cytoplasmic nonribosomal antigan. Arthritis Rhum 1974, 17, 421.
Alspaugh, M.A., Talal, N., Tan E.M., Differentiation and characterization of autoantibodies and their antigens in SjPorgen's syndrome. Arthritis Rheum, 1976, 19, 216.
Sharp, G.C., Irvin, W.S., Gould, G.R., Tan, E.M. Specific antibody to the extractable nuclear antigen (ENA) in the mixed connective tissue disease syndrome. Proceedings of the 42nd Annual Meeting. J Lab Clin Med, 1969, 74, 1010–1011.
Sharp, G.C. Mixed connective tissue disease. Bull Rheum Dis, 1975, 25, 828–831.
Reichlin, M. Problems in differentiating SLE and mixed connective tissue disease. N Eng J Med, 1976, 295, 1194–1195.
Robbins, W.C., Homan, H.R., Deicher, H., Kunkel, H.G. Complement fixation with cell nuclei and CNA in lupus erythematosus. Proceedings of the Society for Experimental Biology (New York), 1957, 96, 575.
Seligmann, M. Mise en évidence dans le serum de malades atteints de lupus érythémateux disséminé d'une substance determinant une réaction de précipitation avec l'acide désoxyribonucléique. CR Acad Sci, 1957, 245, 243.
Miescher, P., Strassle, R., New serological methods for detection of LE factor. Vox Sanguinis, 1957, 2, 283.
Cepellini, R., Polli, E., Celeda, F. A DNA reacting factor in serum of a patient with lupus erythematosus diffusus. Prov Soc Exp Biol (NY), 1957, 96, 572.
Asherson, G.L., Antibodies against nuclear and cytoplasmic cell constituents in systemic lupus erythematosus and other diseases. Br J Exp Pathol, 1959, 40, 209.
Lachmann, P.J., Kunkel, H.G. Correlation of antinuclear antibodies and nuclear staining patterns. Lancet, 1961, 2, 436.
Tan, E.M., Kunke, H.G. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol, 1966, 96, 464.
Tan, E.M. An immunologic precipitin system between soluble nucleoprotein and serum antibody in systemic lupus erythematosus. J Clin Invest, 1967, 46, 735.
Scopelitis, E., Biundo, J.J., Jr., Alspaugh M.A. Anti-SS-A antibody and other antinuclear antibodies in systemic lupus erythematosus. Arthritis Rheum, 1980, 23, 287.
Tan, E.M., Kunkel, H.G. Characteristics of a soluble nuclear antigen pricipitating with sera of patients with systemic lupus erythematosus. J Immunol, 1966, 96, 464.
Fishbein, E., Alarcon-Segovia, D., Vega, J.M. Antibodies to histnes in systemic lupus erythematosus. Clin Exp Immunol, 1979, 36, 145.
Northway, J.D., Tan, E.M. Differentiation of antinuclear antibodies giving speckled staining patterne in immunofluorescende. Clin Immunol Immunopathol, 1972, 1, 140.
Pillarisetty, R.J., Becker, M.J., Palmer, D.W., Tala, N. Antibodies binding polyriboadenylic acid in systemic lupus erythematosus. Immunochemical characterization and isolation by affinity chromatography. Clin Exp Immunol, 1975, 22, 419.
Pillarisetty, R.J., Talal, N. Clinical studies of antibodies binding polyriboadenylic acid in systemic lupus erythematosus. Arthritis Rheum, 1976, 19, 705.
Alspaugh, M.A., Tan, E.M. Serum antibody in rheumatoid arthritis reactive with a cell-associated antigen. Arthritis reactive with a cell-associated antigen. Arthritis Rheum, 1976, 19, 711.
Maddison, P.J., Reichlin, M., Provost, T.T. Association of autoantibodies to certain cytoplasmic antigens with systemic lupus erythematosus and other rheumatic diseases. Arthritis Rheum, 1977, 20, 126 (Abstract).
Provost, T.T., Ahmed, A.R., Maddison, P.J., Reichlin, N. Antibodies to cytoplasmic antigens in lupus erythematosus. Serologic marker for systemic disease. Arthritis Rheum, 1977, 20, 1457.
Wolfe, J.F., Adelstein, E., Sharp, G.C. Antinuclear antiboy with distinct specificity for polymyositis. J. Clin Invest, 1977, 59, 176.
Miyawaki, S., Kohmoto, K., Kurata, N., Ofuji. Identification and characterization of two new soluble nuclear antigens reactive with sera of patients with connective tissue disease. Arthritis Rheum, 1978, 21, 803.
Winn, D.M., Wolfe, J.F., Harmon, D., Sharp G.C. Characterization of a distinct nuclear acidic protein antigen (MA) and clinical findings in sytemic lupus erythematosys patients with MA antibodies. J Clin Invest, 1979, 64, 820.
Tan, E.M., Rodnan, G.P., Garcia, I., Moroi, Y., Fritzler, M.J., Peebles, C. Diversity of antinuclear antibodies in progressive systemic sclerosis. Arhtritis Rheum, 1980, 23, 617.
Nishikai, A., Reichlin, M. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. Arthritis Rheum, 1980, 23, 881.
Smeenk, R., Aarden, L. The use of polyethylene glycol precipitation to detect low-avidity anti-DNA antibodies in systemic lupus erythematosus. J Immunol Methods, 1980, 39, 165–180.
Smeenk, R., van der Lelij, G., Aarden, L. Avidity of antibodies to dsDNA. Comparison of IFT on Chrithidia Luciliae, FARR assay and PEG assay, J Immunol, 1982, 128, 73–78.
Weston, W.L., Franco, H.L., Tan, E. Association of antibodies to sicca syndrome antigens in newborns with lupus erythematosus and their mothers. Clin Res, 1980, 28, 582.
Scott, J.S., Maddison, P.J., Taylor, P.V., Esscher, E., Scott, O., Skinner, R.P. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med, 1983, 309(4), 209–212.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Walravens, M. Systemic diseases and the detection of antinuclear and anticytoplasmic antibodies. An hystorical review. Clin Rheumatol 6 (Suppl 1), 9–17 (1987). https://doi.org/10.1007/BF02200709
Issue Date:
DOI: https://doi.org/10.1007/BF02200709